Navigation Links
Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings
Date:3/18/2011

CAMBRIDGE, Mass., March 18, 2011 /PRNewswire/ -- Cytel Inc., premier provider of clinical trial design and implementation services and software, proudly announced today the addition of pharmaceutical and biotech industry veteran Jim Baker as Vice President, Clinical Research Services.

Over his 28 year career, Baker has demonstrated biopharmaceutical development leadership at some of the world's top pharmaceutical, biotech and clinical research firms including Amgen®, Wyeth® and Parexel®. Most recently Baker served as Senior Director of Study Standards Implementation at Millennium®.

Jim Baker is respected not only for his cross-functional experience spanning both development planning and clinical operations, but also equally for his in-depth trial data management knowledge.

Cytel CEO Ranganath Nayak remarked: "Jim's talent and track record are a precise match for Cytel's expanding line of innovative Clinical Research Services. Our customers will be happy that we have someone who has walked many a mile in their shoes and understands not only what their needs are but also how best to align Cytel's capabilities with those needs."

Baker has officially assumed his new position and it is our distinct pleasure to welcome him as the newest member of the Cytel management team.

About Cytel

Cytel Inc. is a leading provider of clinical research services and trial design and analysis software primarily for the biopharmaceutical and medical device development markets.

Cytel pioneered the statistical science of adaptive clinical trials and has designed more validated adaptive trials than any other service provider. Cytel software is used by 47 of the top 50 biopharmaceutical companies to design, monitor and analyze their clinical trials.


'/>"/>
SOURCE Cytel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies
2. Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health (CDRH)
3. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
4. Judith Quinlan Joins Cytel as Vice President, Adaptive Trials
5. Accuray Hires Chief Marketing Officer
6. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
7. Pharmaceutical Institute Hires Nathan Pienkowski, Ph.D., to Head Instructional Design
8. Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America
9. Accuray Hires General Manager for the Asia Pacific Region
10. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
11. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , April 24, 2017 Solentim, the ... announced the addition of a major new product ... Plate Seeding,). The VIPS has been developed for ... well microplates as part of the process to ... a simple and more reliable solution when compared ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... Hackensack, N.J. has been honored by Enterprising Women magazine as one of its ... world’s top women business owners. Winners have demonstrated that they have fast-growth businesses, ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
Breaking Medicine News(10 mins):